Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice

Immunology

Volumn 110, Issue 3, 2003, Pages 368-375

  Pal, Sukumar ^a   Peterson, Ellena M ^a   De La Maza, Luis M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; CHLAMYDIA TRACHOMATIS MOUSE PNEUMONITIS BIOVAR; CHLAMYDIASIS; CLINICAL PROTOCOL; CONTROLLED STUDY; EMBRYO; FEMALE; FEMALE FERTILITY; GENITAL TRACT INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INFERTILITY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CELLS, CULTURED; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENITAL DISEASES, FEMALE; INFERTILITY, FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SPECIES SPECIFICITY; SPLEEN; VAGINA;

EID: 0242468265     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01748.x     Document Type: Article

References (50)

1. Grayston JT, Wang SP. New knowledge of Chlamydiae and the diseases they cause. J Infect Dis 1975; 132:87-105.
2. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Human Reprod Update 1999; 5:433-47.
3. Schachter J. Infection and disease epidemiology. In: Stephens, RS, ed. Chlamydia: Intracellular Biology, Pathogenesis, and Immunity. Washington, DC: ASM Press, 1999:139-69.
4. Stamm WE. Chlamydia trachomatis infections of the adult. In: Holmes, KK et al., eds. Sexually Transmitted Diseases. New York: McGraw-Hill, 1999:407-22.
5. Cates W and the American Social Health Association Panel. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis 1999; 26:S2-7.
6. Westrom L, Joesoef R, Reynolds D, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility, a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopy. Sex Transm Dis 1992; 19:185-92.
7. Westrom L, Mardh PA. Chlamydial salpingitis. Br J Bull 1990; 39:145-50.
8. Bavoil PM, Hsia RC, Rank RG. Prospects for a vaccine against Chlamydia genital disease I-Microbiology and pathogenesis. Bull Inst Pasteur 1996; 9:5-54.
9. de la Maza MA, de la Maza LM. A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine 1995; 13:119-27.
10. de la Maza LM, Peterson EM. Vaccines for Chlamydia trachomatis infections. Curr Opin Invest Drugs 2002; 3:980-6.
11. Grayston JT, Wang SP. The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. Sex Transm Dis 1978; 5:73-7.
12. Stagg AJ. Vaccines against Chlamydia: approaches and progress. Mol Med Today 1998; 4:166-73.
13. Stephens RS. Chlamydial genomics and vaccine antigen discovery. J Infect Dis 2001; 181 (Suppl. 3):S521-3.
14. Igietseme JU, Eko FO, Black CM. Contemporary approaches to designing and evaluating vaccines against Chlamydia. Exper Rev Vaccines 2003; 2:129-46.
15. Ada G. The immunology of vaccination. In: Plotkin, SA, Orenstein, WA, eds. Vaccines. Philadelphia: W.B. Saunders, 1999:28-39.
16. Rank RG. Models of immunity. In: Stephens, RS, ed. Chlamydia: Intracellular Biology, Pathogenesis, and Immunity. Washington, DC: American Society for Microbiology, 1999:239-95.
17. Darville T, Andrews CW, Laffoon KK, Shymasani W, Kishen LR, Rank RG. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect Immun 1997; 65:3065-73.
18. Darville T, Andrews CW, Sikes JD, Fraley PL, Rank RG. Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection. Infect Immun 2001; 69:3556-61.
19. de la Maza LM, Pal S, Khamesipour A, Peterson EM. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun 1994; 62: 2094-7.
20. Tuffrey M, Falder P, Gale J, Taylor-Robinson D. Salpingitis in mice induced by human strains of Chlamydia trachomatis. Br J Exp Pathol 1986; 67:605-16.
21. Yan X, HayGlass KT, Brunham RC. Genetically determined differences in IL-10 and IFN-γ response correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 1996; 156:4338-44.
22. Stagg AJ, Tuffrey M, Woods C, Wunderink E, Knight SC. Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect Immun 1998; 66:3535-44.
23. Pal S, Fielder TJ, Peterson EM, de la Maza LM. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 1994; 62:3354-62.
24. Pal S, Peterson EM, de la Maza LM. Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge. Infect Immun 1996; 64:5341-8.
25. Nigg C. An unidentified virus which produces pneumonia and systemic infection in mice. Science 1942; 99:49-50.
26. Swenson CE, Schachter J. Infertility as a consequence of chlamydial infection of the upper genital tract in female mice. Sex Trans Dis 1984; 11:64-7.
27. Peterson EM, Zhong G, Carlson E, de la Maza LM. Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity. Infect Immun 1988; 56:885-91.
28. Schagger H, Von Jagow G. Tricine-sodium dodecyl sulphate polyacrylamide gel electrophoresis for the separation of protein range I-100 kDa. Anal Biochem 1987; 166:368-79.
29. Pal S, Pu Z, Huneke RB, Taylor HR, Whittum-Hudson JA. Chlamydia-specific lymphocytes in conjunctiva during ocular infection: limiting dilution analysis. Regional Immunol 1991; 3:171-6.
30. Brunham RC, Kuo CC, Cles L, Holmes KK. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun 1983; 39:1491-4.
31. Igietseme JU, Ramsey KH, Magee DM, Williams DM, Kincy TJ, Rank RG. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific ThI lymphocyte clone. Reg Immunol 1993; 5:317-24.
32. Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect Immun 2002; 70:2741-51.
33. + cells. Infect Immun 2001; 69:2643-9.
34. Pal S, Theodor I, Peterson EM, de la Maza LM. Monoclonal immunogloblin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge. Vaccine 1997; 15: 575-82.
35. Ramsey KH, Rank RG. Resolution of chlamydial genital infection with antigen specific T-lymphocyte lines. Infect Immun 1991; 59:925-31.
36. Roizman B. Introduction: objectives of herpes simplex virus vaccines seen from historical perspective. Rev Infect Dis 1991; 13:S892-4.
37. Morrison RP, Belland RJ, Lyng K, Caldwell HD. Chlamydial disease pathogenesis. The 57-kDa chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 1989; 170:113-22.
38. Stephens RS. Genomic autobiographies of Chlamydiae. In. Stephens RS, ed. Chlamydia: Intracellular Biology, Pathogenesis and Immunity. Washington DC: American Society for Microbiology. 1999:9-28.
39. Pal S, Theodor I, Peterson EM, de la Maza LM. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge. Infect Immun 1997; 65:3361-9.
40. Pal S, Barnhart KM, Wei Q, Abai AM, Peterson EM, de la Maza LM. Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge. Vaccine 1999; 17:459-65.
41. Pal S, Theodor I, Peterson EM, de la Maza LM. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge. Infect Immun 2001; 69:6240-7.
42. Tuffrey M, Alexander F, Conlan W, Woods C, Ward M. Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein. J Gen Microbiol 1992; 148: 1707-15.
43. Zhang DJ, Yang X, Berry J, Shen C, McClarty G, Brunham RC. DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J Infect Dis 1997; 176:1035-40.
44. Longbottom D, Russel M, Jones GE, Lainson FA, Herring AJ. Identification of a multigene family coding for the 90 kDa proteins of the ovine abortion subtype of Chlamydia psittaci. FEMS Microbiol Lett 1996; 142:277-81.
45. Barron AL, White HJ, Rank RG, Soloff BL, Moses EB. A new animal model for the study of Chlamydia trachomatis genital infection of mice with the agent of mouse pneumonitis. J Infect Dis 1981; 143:63-6.
46. Tuffrey M, Taylor-Robinson D. Progesterone as a key factor in the development of a mouse genital-tract infection with Chlamydia trachomatis. FEMS Microbiol Lett 1981; 12:111-5.
47. Pal S, Peterson EM, de la Maza LM. Susceptibility of mice to a vaginal infection with Chlamydia trachomatis mouse pneumonitis is dependent on the age of the animal. Infect Immun 2001; 69:5203-6.
48. Grossman JC. Interactions between the gonadal steroids and the immune system. Science 1985; 227:257-61.
49. Kaushic C, Zhou F, Murdin AD, Wira CR. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect Immun 2000; 68:4207-16.
50. Piccinni MP, Giudizi MG, Biagiotti R et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established ThI cell clones. J Immunol 1995; 155:128-33.